| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| T2 Biosystems, Inc. | Chief Commercial Officer | Restricted Stock Units | 180,000 | $28,350 | $0.1575 | 04 Nov 2024 | Direct |
| T2 Biosystems, Inc. | Chief Commercial Officer | Common Stock | 77 | $12 | $0.1575 | 20 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TTOO | T2 Biosystems, Inc. | 04 Nov 2024 | 2 | $0 | 4 | Chief Commercial Officer | 02 Jan 2025, 18:55 |
| TTOO | T2 Biosystems, Inc. | 20 Feb 2024 | 2 | $0 | 4 | Chief Commercial Officer | 20 Feb 2024, 16:00 |
| TTOO | T2 Biosystems, Inc. | 08 Nov 2023 | 2 | $0 | 4 | Chief Commercial Officer | 28 Nov 2023, 16:05 |
| TTOO | T2 Biosystems, Inc. | 20 Feb 2023 | 3 | -$349 | 4/A | Chief Commercial Officer | 28 Nov 2023, 16:00 |
| TTOO | T2 Biosystems, Inc. | 08 Nov 2022 | 3 | -$2,317 | 4 | Chief Commercial Officer | 22 Nov 2022, 15:00 |
| TTOO | T2 Biosystems, Inc. | 08 Apr 2022 | 1 | +$5,183 | 4 | Chief Commercial Officer | 11 Apr 2022, 09:38 |
| TTOO | T2 Biosystems, Inc. | 26 Feb 2022 | 1 | $0 | 4 | Chief Commercial Officer | 30 Mar 2022, 16:05 |
| TTOO | T2 Biosystems, Inc. | 20 Feb 2022 | 1 | $0 | 4 | Chief Commercial Officer | 23 Feb 2022, 18:22 |
| TTOO | T2 Biosystems, Inc. | 08 Nov 2021 | 0 | $0 | 3/A | Chief Commercial Officer | 30 Mar 2022, 16:00 |